ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 735001 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 735001; 2) Community: the network communities that were significantly associated with the response to NSC 735001; 3) Molecule: the relationships between components within communities and NSC 735001; 4) MDR: the compounds that were significantly associated with the NSC 735001.

NSC Compound Enrichment Correlation
NSC 715664 Phenol, 4-(5,6-dimethyl-1H-benzimidazol-2-yl)- 2,6-bis(1,1-dimethylethyl)- 0.00227699677919298 0.31410766
NSC 722779 dabequine 0.00227699677919298 0.1536348
NSC 726718 3-(Benzothiazol-6-ylamino)-7-chloro-8-methyl-1,1,-dioxo-4H-1 ,5,2-benzodithiazepin-4-ylideneacetic acid 0.00227699677919298 0.32619974
NSC 727985 NSC 708781 incorporated in micelles, 0.55% (w/w) of drug 0.00227699677919298 0.49328052
NSC 747448 3,19-(2,6-Dimethyoxy)benzylidineandrographolide 0.00227699677919299 0.29150884
NSC 109451 Null 0.00228818143845077 -0.29340296
NSC 176503 Fastigilin B 0.00228818143845077 0.1953583
NSC 201290 Octadecanamide, N-(1.beta.-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)- 0.00228818143845077 0.33308415
NSC 309401 2H-Pyrrolo[3,2-f]quinazoline-2,4(3H)-diamine, 3-[(3-aminophenyl)methyl]-, dihydrochloride 0.00228818143845077 0.34509528
NSC 617309 Null 0.00228818143845077 0.38668467
Total:163  Current:22    [First] [Prev] [Next] [Last]